Comparison of Efficacy and Safety of Cytisine against Nicotine Replacement Treatment
This study provides supportive evidence for the routine clinical use of cytisine as a first-line smoking cessation treatment, especially in low- and middle-income countries. Its affordability, tolerability, and short treatment duration offer distinct advantages for public health implementation.
Authors
- Belma Akbaba Bağcı (ORCID: https://orcid.org/0000-0003-4039-4860)
- Celal Satıcı (ORCID: https://orcid.org/0000-0002-5457-9551)
- Şule Gül (ORCID: https://orcid.org/0000-0002-7162-2611)
- Ayşegül ERİNÇ (ORCID: https://orcid.org/0000-0001-8822-7944)
- Banu Kahriman (ORCID: https://orcid.org/0000-0002-9147-8602)
- Ali Kirac (ORCID: https://orcid.org/0009-0005-3364-9716)
Institutions
- Sağlık Bilimleri Üniversitesi (TR)
- Yedikule Teaching Hospital (TR)
Publication Details
- Journal
- Nicotine & Tobacco Research
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1093/ntr/ntaf241
- Primary Topic
- Smoking Behavior and Cessation
- Type
- article
- Field-Weighted Citation Impact
- 0.00